426 related articles for article (PubMed ID: 19003550)
41. Autonomic and cognitive functions in Parkinson's disease (PD).
Oh ES; Lee JH; Seo JG; Sohn EH; Lee AY
Arch Gerontol Geriatr; 2011; 52(1):84-8. PubMed ID: 20223528
[TBL] [Abstract][Full Text] [Related]
42. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
Martínez-Martín P; Forjaz MJ; Cubo E; Frades B; de Pedro Cuesta J;
Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
[TBL] [Abstract][Full Text] [Related]
43. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers.
Pal PK; Thennarasu K; Fleming J; Schulzer M; Brown T; Calne SM
Parkinsonism Relat Disord; 2004 Mar; 10(3):157-68. PubMed ID: 15036171
[TBL] [Abstract][Full Text] [Related]
44. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
[TBL] [Abstract][Full Text] [Related]
45. Direct medical costs associated with Parkinson's disease: a population-based study.
Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA
Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
[TBL] [Abstract][Full Text] [Related]
46. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
[TBL] [Abstract][Full Text] [Related]
47. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
[TBL] [Abstract][Full Text] [Related]
48. Trends in resource utilization for Parkinson's disease in Germany.
Winter Y; Balzer-Geldsetzer M; von Campenhausen S; Spottke A; Eggert K; Oertel WH; Dodel R
J Neurol Sci; 2010 Jul; 294(1-2):18-22. PubMed ID: 20493500
[TBL] [Abstract][Full Text] [Related]
49. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT.
Visser M; Marinus J; Stiggelbout AM; Van Hilten JJ
Mov Disord; 2004 Nov; 19(11):1306-12. PubMed ID: 15390007
[TBL] [Abstract][Full Text] [Related]
50. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
51. The economic impact of cognitive impairment in Parkinson's disease.
Vossius C; Larsen JP; Janvin C; Aarsland D
Mov Disord; 2011 Jul; 26(8):1541-4. PubMed ID: 21538519
[TBL] [Abstract][Full Text] [Related]
52. Burden of disease related to Parkinson's disease in Spain in the year 2000.
Cubo E; Alvarez E; Morant C; de Pedro Cuesta J; Martínez Martín P; Génova R; Freire JM
Mov Disord; 2005 Nov; 20(11):1481-7. PubMed ID: 16037922
[TBL] [Abstract][Full Text] [Related]
53. Psychological adjustment has a greater effect on health-related quality of life than on severity of disease in Parkinson's disease.
Suzukamo Y; Ohbu S; Kondo T; Kohmoto J; Fukuhara S
Mov Disord; 2006 Jun; 21(6):761-6. PubMed ID: 16511869
[TBL] [Abstract][Full Text] [Related]
54. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications.
Storch A; Schneider CB; Wolz M; Stürwald Y; Nebe A; Odin P; Mahler A; Fuchs G; Jost WH; Chaudhuri KR; Koch R; Reichmann H; Ebersbach G
Neurology; 2013 Feb; 80(9):800-9. PubMed ID: 23365054
[TBL] [Abstract][Full Text] [Related]
55. Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.
Carod-Artal FJ; Mesquita HM; Ziomkowski S; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Nov; 19(11):943-8. PubMed ID: 23831481
[TBL] [Abstract][Full Text] [Related]
56. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
[TBL] [Abstract][Full Text] [Related]
57. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
[TBL] [Abstract][Full Text] [Related]
58. Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.
Martinez-Martín P; Rodriguez-Blazquez C; Paz S; Forjaz MJ; Frades-Payo B; Cubo E; de Pedro-Cuesta J; Lizán L;
PLoS One; 2015; 10(12):e0145310. PubMed ID: 26698860
[TBL] [Abstract][Full Text] [Related]
59. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
60. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
